EHMSG 2020 Virtual Conference | Live Sessions

PROGRAMME

SATURDAY, SEPTEMBER 12, 2020

All times are Central European Summer Time (CEST)

08.30 – 08.50          I - Introductory Lecture

A tribute to George Sachs: pH & Hp revisited, then and now

Richard Hunt, Hamilton, ON, Canada

 

08.50 – 09.50          II - Gastric Epithelium Homeostasis in Health and Disease

08.50 – 09.10                    Unexpected role of TLR5: Flagellin-independent but T4SS-dependent activation controls 

                                 Helicobacter pylori infections

Steffen Backert, Erlangen, Germany

09.10 – 09.30                    Molecular mechanisms in epithelial barrier integrity

Ceu Figueiredo, Porto, Portugal

 

09.30  09.50                      Gastric organoids as a tool to study Helicobacter infection

Francesco Boccellato, Oxford, UK


09.50 – 10.00                    10 minutes break

10.00 – 12.30           III - Symposium: H. pylori diagnostics & treatment 

 

10.00 – 10.20                    “Test and Treat” strategy with UBT: a cost effective strategy for the management of H. pylori

                                            infection in UK

Mark Pritchard, Liverpool, UK

 

10.20 – 10.40                    Rationale behind UBT H. pylori screening and eradication therapy to reduce the risk of Upper GI

                                            bleeding in patients with myocardial Infarction. Insights from the HELP-PILOT study 

Magnus Bäck, Stockholm, Sweden

 

10.40 – 11.00                    Acid suppression – how much is needed?

Takahisa Furuta, Hamamatsu, Japan

 

11.00 – 11.20                    Renaissance reviewed - Bismuth still needed?

Peter Malfertheiner, Magdeburg, Germany

 

11.20 – 11.30                    10 minutes break

 

11.30 – 11.50                    Overcoming antibiotic resistance – the Korean experience

Ji Yong Ahn, Ulsan, Korea

 

11.50 – 12.10                    Guidelines are good – adherence is better

Pali Hungin, Durham, UK

 

12.10 – 12.30                    Management of H. pylori infection based on global/regional guidelines

Seung Joo Kang, Seoul, Korea

 

12.30 – 12.35          IV - Presentation of the Journal "Microbiota in Health and Disease"

                                           Francesco Franceschi, Rome, Italy

12.35 – 12.40          V - Awarding of the Marshall & Warren Medal to Hazel Mitchell, Australia

                                           Hazel Mitchell, Sydney, Australia


12.40 – 13.40          Lunch break


13.40 – 14.40          VI - Sponsored Symposium


14.40 – 15.40          VII - Gut Microbiota in Health and Disease 

 

14.40 – 15.00                    Microbial Therapeutics: Are we there yet? Clinicians perspective

Tariq Iqbal, Birmingham, UK

 

15.00 – 15.20                    Using the microbiome to turn liquid diet into solid food. The CD-TREAT diet for treating Crohn’s

                                            disease

Richard Hansen, Glasgow, UK

15.20 – 15.40                    Microbial transplant – what are the challenges?

Josbert Keller, Leiden, The Netherlands

15.40 – 15.50                    10 minutes break


15.50 – 16.50          VIII - EHMSG Guidelines initiative in microbiota handling

 

15.50 – 16.10                    The challenge of microbiota testing

Antonio Gasbarrini, Rome, Italy

16.10 – 16.30                    Requirements for optimal testing

Mirjana Rajilic-Stojanovic, Belgrade, Serbia

16.30 – 16.50                    Clinical relevance of microbiota signature

Gianluca Ianiro, Rome, Italy

 

16.50 – 17.00                    10 minutes break


17.00 – 19.00           IX - Symposium: Gastric Cancer – Early detection and prevention 2020

 

17.00 – 17.20                    H. pylori in the stomach – factors contributing to its dominance

Richard Peek, Nashville, TN, USA 

 

17.20 – 17.40                    Current epidemiology and gastric cancer patterns

Constanza Camargo, Rockville, USA

 

17.40 – 18.00                    Population-based screening of gastric cancer

Jin-Young Park, Lyon, France

 

18.00 – 18.30                    H. pylori screen-and-treat: Pro & Con - Talk

18.00 – 18.15    Con:    Anthony O'Connor, Dublin, Ireland

18.15 – 18.30    Pro:     Jan Bornschein, Oxford, UK

 

18.30 – 19.00                    Preneoplastic conditions - Tandem Talk

                     18.30 – 18.45    is it time for molecular risk prediction?      Marnix Jansen, London, UK

                                           18.45 – 19.00    how good is endoscopy?                               Alexander Link, Magdeburg, Germany


 

19.00 – 19.15          X - Closing Session

 

19.00 – 19.10                    Poster Awards

19.10 – 19.15                    Presentation of the EHMSG Workshop 2021 in Belgrade

          Mirjana Rajilic-Stojanovic, Belgrade, Serbia

EHMSG 2020

European Helicobacter and Microbiota Study Group

© 2020 EHMSG

Core Agency

WMA GmbH

Alser Strasse 4, 1090 Vienna, Austria

  • zwitschern